Exclusive: U.S. cancer drugmaker Ignyta in advanced sale talks - sources

(Reuters) - Ignyta Inc is in advanced talks to sell itself, people familiar with the matter said on Thursday, just three years after the U.S. cancer drugmaker became a public company focused on precision drugs and diagnostics.